Stroke Trial, Recruiting NCT06848894 Sponsor: Beijing Tiantan Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06848894
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have had a stroke affecting the front part of the brain, and it started within the last 24 hours
  • Your stroke severity falls within a moderate range based on a standard medical scoring test (confirm with trial site)
  • You are receiving or have received clot-busting medication through a drip, or a procedure to remove or dissolve the clot in your blood vessel
  • Before your stroke, you were able to look after yourself independently in day-to-day life
  • You (or a legal representative on your behalf) are able and willing to sign a consent form to take part

Who may not be able to join:

  • A brain scan taken before treatment shows a large area of early stroke damage (confirm with trial site)
  • You have already been given the study drug (HUK) or a medicine containing it since your stroke started
  • You have a known allergy to HUK or medicines containing it, or you have a history of allergies to other drugs or foods
  • You have a history of blood clotting problems, low platelet levels, or active bleeding anywhere in the body (such as in the brain, stomach, gums, or skin), or you are taking blood-thinning medicines like warfarin or rivaroxaban, or you received heparin within 48 hours of your stroke
  • You have been regularly taking a type of blood pressure medicine called an ACE inhibitor (such as captopril or enalapril) within the week before joining the trial
  • You have significant liver disease or poor liver function, or you have significant kidney disease or are on dialysis
  • You have a serious heart or lung condition that the medical team feels makes participation unsuitable
  • You have reasons that make the standard stroke treatments used in this trial unsuitable for you (confirm with trial site)
  • You have a serious illness where life expectancy is less than 3 months
  • You are pregnant or breastfeeding, or you are a woman who could become pregnant and are not using effective contraception or do not have a recent negative pregnancy test
  • You have a mental health condition, cognitive difficulties, physical limitations, or other circumstances that would prevent you from completing the trial
  • You are currently taking part in another clinical trial
  • The medical team has any other concern that makes participation unsuitable for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wang Yilong, MD, PhD, Beijing Tiantan Hospital

Phone: 0086-010-59976274

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Proportion of a favorable outcome (mRS 0-2)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov